Edition:
India

Boston Scientific Corp (BSX.N)

BSX.N on New York Stock Exchange

24.32USD
24 Mar 2017
Change (% chg)

$0.07 (+0.29%)
Prev Close
$24.25
Open
$24.27
Day's High
$24.47
Day's Low
$24.23
Volume
1,175,194
Avg. Vol
2,081,081
52-wk High
$25.65
52-wk Low
$17.78

BSX.N

Chart for BSX.N

About

Boston Scientific Corporation is a developer, manufacturer and marketer of medical devices that are used in a range of interventional medical specialties. The Company offers its products by seven businesses: Interventional Cardiology, Cardiac Rhythm Management, Endoscopy, Peripheral Interventions, Urology and Pelvic Health,... (more)

Overall

Beta: 1.11
Market Cap(Mil.): $33,064.60
Shares Outstanding(Mil.): 1,363.49
Dividend: --
Yield (%): --

Financials

U.S. medtech shares gain as investors seek shelter from drug price debate

NEW YORK, March 13 Investors are seeking shelter in shares of U.S. medical device and supply companies, encouraged by their solid growth prospects and wary that U.S. President Donald Trump's criticism of drug prices makes owning pharmaceutical and biotechnology stocks risky.

14 Mar 2017

BRIEF-German patent court issues initial decision

* District court in Germany ruled that Boston Scientific's lotus valve infringes one of co's patents for transcatheter aortic valves

09 Mar 2017

BRIEF-Boston Scientific receives favorable rulings in Edwards Lifesciences litigation

* Boston scientific receives favorable rulings in edwards lifesciences litigation

09 Mar 2017

BRIEF-Edwards Lifesciences says UK patent court issues decision on transcatheter heart valves

* Edwards Lifesciences Corp says company is not changing its financial guidance

03 Mar 2017

Boston Scientific recalls Lotus Valve heart devices

Boston Scientific Corp said on Thursday it was recalling its Lotus range of heart devices, citing reports of problems with the locking mechanism, sending its shares down as much as 7.4 percent.

23 Feb 2017

Boston Scientific recalls all Lotus Valve heart devices

Feb 23 Boston Scientific Corp said on Thursday it was recalling its range of Lotus Valve heart devices, citing reports of problems with the locking mechanism.

23 Feb 2017

BRIEF-Boston Scientific says on Feb. 23 announced voluntary removal of all Lotus Valve devices - SEC filing

* Boston Scientific - on February 23 co announced voluntary removal of all Lotus Valve devices - SEC filing

23 Feb 2017

U.S. top court rejects Boston Scientific's patent licensing appeal

The U.S. Supreme Court on Tuesday turned away an appeal by Boston Scientific Corp of a Maryland state court jury verdict ordering the medical device company to pay $308 million to a patent licensor for breach of contract concerning implantable cardiac devices.

21 Feb 2017

UPDATE 1-U.S. top court rejects Boston Scientific's patent licensing appeal

Feb 21 The U.S. Supreme Court on Tuesday turned away an appeal by Boston Scientific Corp of a Maryland state court jury verdict ordering the medical device company to pay $308 million to a patent licensor for breach of contract concerning implantable cardiac devices.

21 Feb 2017

U.S. Supreme Court rejects Boston Scientific's patent licensing appeal

Feb 21 The U.S. Supreme Court on Tuesday turned away an appeal by Boston Scientific Corp of a Maryland state court jury verdict ordering the medical device company to pay $308 million to a patent licensor for breach of contract concerning implantable cardiac devices.

21 Feb 2017

More From Around the Web

Competitors

Earnings vs. Estimates